Showing results (141-150 of 367) with videos related to

Sort By:
Pageof 37
The Journal of Biological Chemistry|January 9, 2015
Activatory and inhibitory Fcγ receptors augment rituximab-mediated internalization of CD20 independent of signaling via the cytoplasmic domainAndrew T Vaughan, Claude H T Chan, Christian Klein, et al.
Gastroenterology|January 24, 2007
STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivoAntonello Pietrangelo, Uta Dierssen, Linda Valli, et al.
Physiological Genomics|January 28, 2010
A single acute pharmacological dose of γ-hydroxybutyrate modifies multiple gene expression patterns in rat hippocampus and frontal cortexVéronique Kemmel, Christian Klein, Doulaye Dembélé, et al.
Journal of Clinical Periodontology|March 20, 2024
Increased safety in periodontal surgery: Doppler ultrasound for detection of relevant palatal blood vessels-A proof-of-concept and cross-sectional studyValentin Bartha, Dan Grünfeld, Aleksandra Kopunic, et al.
Journal of Pharmaceutical Sciences|July 29, 2019
PKPD Assessment of the Anti-CD20 Antibody Obinutuzumab in Cynomolgus Monkey is Feasible Despite Marked Anti-Drug Antibody Response in This SpeciesHans Peter Grimm, Eginhard Schick, Dominik Hainzl, et al.
Rheumatology (Oxford, England)|April 14, 2017
Obinutuzumab induces superior B-cell cytotoxicity to rituximab in rheumatoid arthritis and systemic lupus erythematosus patient samplesVenkat Reddy, Christian Klein, David A Isenberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 3, 2013
Recombinant human IL-15 trans-presentation by B leukemic cells from chronic lymphocytic leukemia induces autologous NK cell proliferation leading to improved anti-CD20 immunotherapyEmilie Laprevotte, Gregory Voisin, Loïc Ysebaert, et al.
SLAS Discovery : Advancing Life Sciences R & D|April 30, 2026
Cleaving through complexity: Pan-serotype fluorimetric assays for the dengue virus proteasesMiguel M Macedo, Johannes Lang, Katharina Eckstein, et al.
Future Oncology (London, England)|July 20, 2022
Obinutuzumab in the treatment of B-cell malignancies: a comprehensive reviewAndrew Davies, Arnon P Kater, Jeff P Sharman, et al.
Pharmacogenetics|September 30, 2003
Bupropion and 4-OH-bupropion pharmacokinetics in relation to genetic polymorphisms in CYP2B6Julia Kirchheiner, Christian Klein, Ingolf Meineke, et al.
Pageof 37